Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia

Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia

Abstract Background The treatment approaches of type 2 diabetes (T2D) are being transformed, due to the availability of novel antidiabetic medications, sodium-glucose co-transporter 2 inhibitors (SGLT2ins), and glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Despite their proven beneficial ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Tomislav Kurevija, Dunja Šojat, Ines Bilić-Ćurčić, Silvija Canecki-Varžić, Ljiljana Trtica-Majnarić
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Primary Care
Subjects:
Type 2 diabetes
Cardiovascular risk
SGLT2ins
GLP-1 RAs
Prescribing rates
Prescribing barriers
Online Access:https://doi.org/10.1186/s12875-025-02837-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items